We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.64%
AUM
$1.35B
AUM Growth
-$127M
Cap. Flow
-$209M
Cap. Flow %
-15.46%
Top 10 Hldgs %
31.78%
Holding
120
New
7
Increased
9
Reduced
73
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 28.8%
2 Technology 25.04%
3 Industrials 19.69%
4 Consumer Discretionary 5.9%
5 Materials 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMCL icon
1
Omnicell
OMCL
$1.86B
$50.4M 3.73%
1,473,734
-269,035
-15% -$8.39M
BLKB icon
2
Blackbaud
BLKB
$1.5B
$44.8M 3.31%
659,661
-103,705
-14% -$6.55M
VASC
3
DELISTED
Vascular Solutions Inc
VASC
$44.2M 3.26%
1,060,111
-185,972
-15% -$6.92M
SPSC icon
4
SPS Commerce
SPSC
$2.25B
$44.1M 3.26%
1,454,806
-252,630
-15% -$6.54M
NEOG icon
5
Neogen
NEOG
$2.05B
$44M 3.25%
2,083,963
-349,418
-14% -$6.51M
MLAB icon
6
Mesa Laboratories
MLAB
$539M
$43.1M 3.18%
350,454
-90,652
-21% -$9.76M
CMD
7
DELISTED
Cantel Medical Corporation
CMD
$41.8M 3.09%
608,180
-122,815
-17% -$8.47M
TYL icon
8
Tyler Technologies
TYL
$12.2B
$40.7M 3.01%
244,313
-45,150
-16% -$6.67M
DORM icon
9
Dorman Products
DORM
$4.01B
$38.7M 2.86%
676,718
-142,365
-17% -$7.65M
AAON icon
10
Aaon
AAON
$8.41B
$38.4M 2.84%
2,094,254
-816,757
-28% -$14.8M
LGND icon
11
Ligand Pharmaceuticals
LGND
$6.02B
$37.5M 2.77%
503,738
-158,881
-24% -$11.8M
SSD icon
12
Simpson Manufacturing
SSD
$7.98B
$36M 2.66%
900,420
-175,295
-16% -$6.74M
HSTM icon
13
HealthStream
HSTM
$793M
$33.8M 2.5%
1,273,610
-228,855
-15% -$5.38M
HCSG icon
14
Healthcare Services Group
HCSG
$1.56B
$32.6M 2.41%
788,261
-133,925
-15% -$5.14M
ALGN icon
15
Align Technology
ALGN
$12B
$32.3M 2.38%
400,620
-71,480
-15% -$5.47M
STMP
16
DELISTED
Stamps.com, Inc.
STMP
$32.2M 2.38%
367,914
-136,720
-27% -$12.2M
EXPO icon
17
Exponent
EXPO
$2.98B
$32M 2.37%
1,097,234
-132,220
-11% -$3.44M
EGOV
18
DELISTED
NIC Inc
EGOV
$32M 2.36%
1,458,425
-312,660
-18% -$6M
CSGP icon
19
CoStar Group
CSGP
$11.3B
$31M 2.29%
1,415,560
-233,450
-14% -$4.62M
FLTX
20
DELISTED
Fleetmatics Group PLC
FLTX
$30.3M 2.24%
698,328
-121,290
-15% -$4.83M
PRLB icon
21
Protolabs
PRLB
$1.86B
$30.2M 2.23%
524,581
-103,287
-16% -$6.89M
RGEN icon
22
Repligen
RGEN
$7.44B
$28.9M 2.14%
1,057,588
-36,835
-3% -$942K
ACIW icon
23
ACI Worldwide
ACIW
$5.72B
$28.7M 2.12%
1,472,028
-256,815
-15% -$5.21M
EPAY
24
DELISTED
Bottomline Technologies Inc
EPAY
$27.6M 2.04%
1,283,685
-485,505
-27% -$12.7M
ROL icon
25
Rollins
ROL
$18.6B
$27.1M 2%
2,082,715
-299,086
-13% -$3.67M

Similar funds

Conestoga Capital Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Conestoga Capital Advisors held 120 positions worth $1.35B, down 8.6% from $1.48B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Conestoga Capital Advisors withdrew a net $209M in Q2 2016, closing 4 positions and reducing 73 holdings. Its most notable exit was Advisory Board Co, an estimated $16.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.

Against the trend, Conestoga Capital Advisors opened a new position in PRESS GANEY HOLDINGS INC COM STK (DE) worth $20.5M.

  • Conestoga Capital Advisors's largest Q2 2016 buy was PRESS GANEY HOLDINGS INC COM STK (DE): 521,044 shares worth $20.5M.
  • Conestoga Capital Advisors added most to Magnite in Q2 2016, an estimated $7.21M increase.
  • Conestoga Capital Advisors's biggest Q2 2016 reduction was Aaon, cutting an estimated $14.8M.
  • Conestoga Capital Advisors fully exited Advisory Board Co in Q2 2016, selling an estimated $16.2M.
  • Conestoga Capital Advisors's ten largest holdings make up 32% of its $1.35B portfolio in Q2 2016.
  • Conestoga Capital Advisors opened 7 new positions and closed 4 in Q2 2016.
  • Conestoga Capital Advisors's portfolio value fell 8.6% quarter-over-quarter to $1.35B.

Based on Conestoga Capital Advisors's 13F filing for Q2 2016, filed 22 Jul 2016.